FUCHS JAMES J 4

4 · PRAXAIR INC · Filed Jan 31, 2011

Insider Transaction Report

Form 4

Period: 2011-01-28

PRAXAIR INCPX

FUCHS JAMES J

Senior Vice President

Transactions

Exercise/Conversion
Common Stock
2011-01-28$53.98/sh+62,600$3,379,148→ 67,086 total
Sale
Common Stock
2011-01-28$91.10/sh−62,600$5,702,860→ 4,486 total
Exercise/Conversion
Common Stock
2011-01-31$61.47/sh+69,400$4,266,018→ 73,886 total
Sale
Common Stock
2011-01-31$92.42/sh−69,400$6,413,948→ 4,486 total
Exercise/Conversion
Stock Option (right to buy)
2011-01-28−62,600→ 0 total
Exercise: $53.98From: 2007-02-28Exp: 2016-02-28→ Common Stock (62,600 underlying)
Exercise/Conversion
Stock Option (right to buy)
2011-01-31−69,400→ 0 total
Exercise: $61.47From: 2008-02-27Exp: 2017-02-27→ Common Stock (69,400 underlying)

Holdings

Common Stock
(indirect: By Spouse)
8,129
Common Stock
(indirect: By 401(k))
829.628
Stock Option (right to buy)
Exercise: $83.89From: 2011-02-26Exp: 2018-02-26→ Common Stock (22,000 underlying)
22,000
Deferred Stock
Exercise: $0.00→ Common Stock (1,234.091 underlying)
1,234.091
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (40,000 underlying)
40,000
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (39,220 underlying)
39,220
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (59,560 underlying)
59,560

Footnotes (9)

[F1]The $91.1 price reported is the weighted average sale price. The sale prices ranged from $91.00 to $91.19 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
[F2]The $92.42 price reported is the weighted average sale price. The sale prices ranged from $92.39 to $92.51 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
[F3]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
[F4]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2009.
[F5]This option will vest in full if Praxair, Inc. achieves cumulative fiscal year earnings per share growth of at least 33% over 2007 earnings per share at any time prior to January 1, 2011. If vested, the option may be exercised beginning on the third anniversary of the grant date. If Praxair, Inc. fails to meet the cumulative earnings per share goal, this option will be forfeited.
[F6]This option vests over three years in three consecutive equal annual installments beginning on February 24, 2010.
[F7]This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
[F8]Conversion to Praxair Common Stock is on a 1-for-1 basis.
[F9]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT